Ignacio Rojas

Ignacio Rojas

Auto-generated profile, based on publicly available information

Ignacio Rojas

Faculty of Medicine, University of Chile, Santiago, Chile

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2020 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
SOSofía Orellana-Urzúa
Sofía Orellana-Urzúa
IRIgnacio Rojas
Ignacio Rojas
LLLucas Líbano
Lucas Líbano
RRRamón Rodrigo
Ramón Rodrigo
Stroke is the second leading cause of mortality and the major cause of adult physical disability worldwide. The currently available treatment to recanalize the blood flow in acute ischemic stroke is intravenous administration of tissue plasminogen activator (t-PA) and endovascular treatment. Nevertheless, those treatments have the disadvantage that reperfusion leads to a highly harmful reactive oxygen species (ROS) production, generating oxidative stress (OS), which is responsible for most of the ischemia-reperfusion injury and thus causing brain tissue damage. In addition, OS can lead brain cells to apoptosis, autophagy and necrosis. The aims of this review are to provide an updated overview of the role of OS in brain IRI, providing some bases for therapeutic interventions based on counteracting the OS-related mechanism of injury and thus suggesting novel possible strategies in the prevention of IRI after stroke.